Table 3 Clinical characteristics of patients in survival analysis
Characteristics | Training (N = 217) | Testing (N = 78) | P value |
|---|---|---|---|
Stage | 0.378 | ||
IA | 132 (60.8) | 52 (66.7) | |
IB | 67 (30.9) | 23 (29.5) | |
II-III | 18 (8.3) | 3 (3.8) | |
Follow-up time (month) | 0.637 | ||
Mean ± standard deviation | 55 ± 21.8 | 58 ± 23.4 | |
Median (25th, 75th) | 57 (47–66) | 57 (51–66) | |
Number of recurrence | |||
All | 47 (21.7) | 15 (19.2) | 0.652 |
At 1 year | 13 (6.0) | 3 (3.8) | |
At 2 years | 21 (9.7) | 7 (9.0) | |
At 3 years | 29 (13.4) | 9 (11.5) | |
DFS, mean with 95% CI (month) | |||
All | 90 (84, 95) | 99 (90, 107) | 0.634 |
Low-risk group based on Rad-score | 96 (92, 101) | 104 (98, 110) | – |
high-risk group based on Rad-score | 71 (60, 81) | 89 (75, 102) | – |